Literature DB >> 6697321

Experimental antitumor activity of 5'-nor-anhydrovinblastine navelbine.

R Maral, C Bourut, E Chenu, G Mathé.   

Abstract

We have found that navelbine, a new semi-synthetic Vinca alkaloid analogue, is as active as vincristine on implanted murine tumors. It has a low cross-resistance with vincristine and vindesine.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6697321     DOI： 10.1016/0304-3835(84)90042-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  11 in total

1.  A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor.

Authors:  Shih-Hung Yang; Chia-Chi Lin; Zhong-Zhe Lin; Yun-Long Tseng; Ruey-Long Hong
Journal:  Invest New Drugs       Date:  2010-09-01       Impact factor: 3.850

2.  Efficacy of 5'-nor-anhydrovinblastine (vinorelbine), against freshly explanted clonogenic human tumor cells in vitro.

Authors:  I Djuanda; H Depenbrock; R Peter; T Block; G Pohlmann; J Rastetter; A R Hanauske
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

Review 3.  Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.

Authors:  K L Goa; D Faulds
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

4.  Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C.

Authors:  W Scheithauer; G Kornek; K Haider; W Kwasny; T Schenk; R Pirker; D Depisch
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 5.  Preclinical and clinical pharmacology of vinca alkaloids.

Authors:  X J Zhou; R Rahmani
Journal:  Drugs       Date:  1992       Impact factor: 9.546

6.  Pharmacokinetics of a new anticancer drug, navelbine, in patients. Comparative study of radioimmunologic and radioactive determination methods.

Authors:  P Boré; R Rahmani; J van Cantfort; C Focan; J P Cano
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography.

Authors:  O van Tellingen; A V Kuijpers; J H Beijnen; W J Nooijen; A Bult
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

8.  Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats.

Authors:  R Rahmani; F Guéritte; M Martin; S Just; J P Cano; J Barbet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Pharmacokinetics of navelbine after oral administration in cancer patients.

Authors:  X J Zhou; P Boré; S Monjanel; Z Sahnoun; R Favre; A Durand; R Rahmani
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

10.  Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.

Authors:  M Kobayashi; T Natsume; S Tamaoki; J Watanabe; H Asano; T Mikami; K Miyasaka; K Miyazaki; M Gondo; K Sakakibara; S Tsukagoshi
Journal:  Jpn J Cancer Res       Date:  1997-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.